1-5 of 5
Frank Kuhr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clearance of Circulating Multiple Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Binod Dhakal, Michael Slade, Ravi Narra, Mostafa E. Mohamed, Othman S. Akhtar, Hima Bansal, Maria Jose Acevedo-Calado, Oren Pasvolsky, Mahmoud R. Gaballa, Melody R. Becnel, Donna M. Weber, Krina K. Patel, Sheeba K. Thomas, J Christine Ye, Frank Kuhr, Bamboo Dong, Shemeeakah Powell, Thai Bui, Meera Mohan, Marcelo C. Pasquini, Anita D'Souza, Halyna Knysh, Robert Z. Orlowski, Maher Albitar, Hans C. Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 4687.
https://doi.org/10.1182/blood-2024-209181
Published: 2024
Journal Articles

Safety and Efficacy of Ibrutinib Maintenance (I-M) Following Frontline Induction in Mantle Cell Lymphoma (MCL) with Sequential Assessment of Changes in NGS-MRD

Reem Karmali, Jeremy S. Abramson, Deborah M. Stephens, Jeffrey A Barnes, Jason Kaplan, Jane N. Winter, Shuo Ma, Juehua Gao, Adam M Petrich, Ephraim Hochberg, Tak Takvorian, Frank Kuhr, Lik Wee Lee, Valerie Nelson, Leo I. Gordon, Barbara Pro
Journal: Blood
Blood (2021) 138 (Supplement 1): 3530.
https://doi.org/10.1182/blood-2021-144707
Published: 2021
Journal Articles

Ibrutinib Maintenance (I-M) Following Intensive Induction in Mantle Cell Lymphoma (MCL): Efficacy, Safety and Changes in Minimal Residual Disease

Reem Karmali, MDMSc, Jeremy S Abramson, MD MMSc, Deborah M. Stephens, DO, Jeffrey A Barnes, MD PhD, Jason Kaplan, MD, Jane N. Winter, MD, Shuo Ma, MD PhD, Juehua Gao, MD PhD, Adam M Petrich, MD, Ephraim Hochberg, MD, Ronald Takvorian, Frank Kuhr, PhD, Valerie Nelson, MD MBA, Leo I. Gordon, MD, Barbara Pro, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-137695
Published: 2020
Journal Articles

Long-Term Follow-up of Follicular Lymphoma (FL) Patients (pts) Demonstrating Undetectable Minimal Residual Disease (MRD) Using a Next-Generation Based DNA Assay: Support for FL As a Curable Disease

Maryam Sarraf Yazdy, MD, Umair Jarral, MD, Chao Yin, MD, Frank Kuhr, PhD, Allison P. Jacob, Bruce D. Cheson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2813.
https://doi.org/10.1182/blood-2019-127262
Published: 2019
Journal Articles

Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD Evaluation

Reem Karmali, MD, Jeremy S. Abramson, MD MMSc, Deborah M. Stephens, DO, Jeffrey A. Barnes, MD PhD, Jason Kaplan, MD, Jane N. Winter, MD, Shuo Ma, MD PhD, Juehua Gao, MD PhD, Adam M. Petrich, MD, Ephraim Hochberg, MD, Ronald W. Takvorian, MD, Frank Kuhr, PhD, Valerie Nelson, MD MBA, Leo I. Gordon, MD, Barbara Pro, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3990.
https://doi.org/10.1182/blood-2019-126920
Published: 2019